Literature DB >> 22505333

Elevated T2-values in MRI of stroke patients shortly after symptom onset do not predict irreversible tissue infarction.

Susanne Siemonsen1, Ulricke Löbel, Jan Sedlacik, Nils D Forkert, Kim Mouridsen, Leif Østergaard, Götz Thomalla, Jens Fiehler.   

Abstract

Distinct from signal alterations in diffusion-weighted images, T(2)-values are also dependent on tissue water content and known to increase with time from symptom onset in acute ischaemic stroke. The purpose of this study was to evaluate whether there is a detectable increase of T(2)-values in different regions in acute ischaemic stroke in the acute and subacute situation and to study the effect of recanalization on the evaluation of T(2)-values in the subacute phase. In addition, we sought to evaluate whether this increase in T(2)-values is reversible. For this purpose, 22 patients with acute ischaemic stroke in the territory of the middle cerebral artery underwent magnetic resonance imaging including diffusion-weighted imaging, perfusion-weighted imaging, fluid-attenuated inversion recovery to determine final infarct size, time-of-flight-angiography (acute and on day 1 or 2) and a triple echo-T(2)-sequence (calculation of T(2) maps) within 6 h after symptom onset. Images were co-registered and regions of diffusion restriction and prolonged time-to-peak as well as surviving tissue (surviving tissue = time-to-peak - final infarct size) and lesion growth (lesion growth = final infarct size-diffusion restriction) were defined and superimposed onto the quantitative T(2) map. In addition, patients were dichotomized according to recanalization information. Mean quantitative T(2)-values were derived for each patient within each region of interest. Mean T(2)-values for patients with recanalization (n = 15) in surviving tissue region of interest were 115.8 ± 7.2 ms (mean ± SD) and in the lesion growth region of interest 114.6 ± 7.0 ms. T(2)-values for patients without recanalization (n = 7) were 117.7 ± 11.4 ms in surviving tissue region of interest and 117.3 ± 12.1 ms in lesion growth region of interest. There was no significant difference between T(2)-values measured in lesion growth and surviving tissue region of interest for patients with or without recanalization. Even though it has been shown that T(2)-values increase with time from symptom onset within the infarct core, increased T(2)-values in areas of perfusion impairment do not identify irreversible damaged brain tissue and high T(2)-values are even found in tissue that is not part of the final infarct lesion and can therefore normalize. In conclusion, this study suggests that T(2)-values are not a valid imaging biomarker in acute stroke to predict tissue outcome.

Entities:  

Mesh:

Year:  2012        PMID: 22505333     DOI: 10.1093/brain/aws079

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  15 in total

1.  Synthetic T2 mapping is correlated with time from stroke onset: a future tool in wake-up stroke management?

Authors:  Thomas Duchaussoy; Jean-François Budzik; Laurene Norberciak; Lucie Colas; Marta Pasquini; Sebastien Verclytte
Journal:  Eur Radiol       Date:  2019-05-28       Impact factor: 5.315

Review 2.  What is meant by "TICI"?

Authors:  J E Fugate; A M Klunder; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-11       Impact factor: 3.825

3.  EPO-cyclosporine combination therapy reduced brain infarct area in rat after acute ischemic stroke: role of innate immune-inflammatory response, micro-RNAs and MAPK family signaling pathway.

Authors:  Chun-Man Yuen; Kuo-Ho Yeh; Christopher Glenn Wallace; Kuan-Hung Chen; Hung-Sheng Lin; Pei-Hsun Sung; Han-Tan Chai; Yung-Lung Chen; Cheuk-Kwan Sun; Chih-Hung Chen; Gour-Shenq Kao; Sheung-Fat Ko; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

4.  Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2 ) mapping.

Authors:  Junghun Cho; Shun Zhang; Youngwook Kee; Pascal Spincemaille; Thanh D Nguyen; Simon Hubertus; Ajay Gupta; Yi Wang
Journal:  Magn Reson Med       Date:  2019-09-10       Impact factor: 4.668

5.  A fast multiparameter MRI approach for acute stroke assessment on a 3T clinical scanner: preliminary results in a non-human primate model with transient ischemic occlusion.

Authors:  Xiaodong Zhang; Frank Tong; Chun-Xia Li; Yumei Yan; Govind Nair; Tsukasa Nagaoka; Yoji Tanaka; Stuart Zola; Leonard Howell
Journal:  Quant Imaging Med Surg       Date:  2014-04

6.  Association of FLAIR vascular hyperintensity and acute MCA stroke outcome changes with the severity of leukoaraiosis.

Authors:  W J Shang; L M Shu; X Zhou; H Q Liao; X H Chen; H Hong; H B Chen
Journal:  Neurol Sci       Date:  2020-05-06       Impact factor: 3.307

7.  T2 relaxation time of the normal-appearing white matter is related to the cognitive status in cerebral small vessel disease.

Authors:  Annemarie Brandhofe; Christoph Stratmann; Jan-Rüdiger Schüre; Ulrich Pilatus; Elke Hattingen; Ralf Deichmann; Ulrike Nöth; Marlies Wagner; René-Maxime Gracien; Alexander Seiler
Journal:  J Cereb Blood Flow Metab       Date:  2020-12-16       Impact factor: 6.200

8.  Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial.

Authors:  Tzu-Hsien Tsai; Cheng-Hsien Lu; Christopher Glenn Wallace; Wen-Neng Chang; Shu-Feng Chen; Chi-Ren Huang; Nai-Wen Tsai; Min-Yu Lan; Pei-Hsun Sung; Chu-Feng Liu; Hon-Kan Yip
Journal:  Crit Care       Date:  2015-02-25       Impact factor: 9.097

9.  Evaluation of white matter myelin water fraction in chronic stroke.

Authors:  M R Borich; A L Mackay; I M Vavasour; A Rauscher; L A Boyd
Journal:  Neuroimage Clin       Date:  2013-04-21       Impact factor: 4.881

10.  Machine Learning-Based Prediction of Brain Tissue Infarction in Patients With Acute Ischemic Stroke Treated With Theophylline as an Add-On to Thrombolytic Therapy: A Randomized Clinical Trial Subgroup Analysis.

Authors:  Boris Modrau; Anthony Winder; Niels Hjort; Martin Nygård Johansen; Grethe Andersen; Jens Fiehler; Henrik Vorum; Nils D Forkert
Journal:  Front Neurol       Date:  2021-05-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.